WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
VANCOUVER, BC and TORONTO, July 17, 2024 /PRNewswire/ – WELL Health Technologies Corp. (TSX:WELL) (OTCQX: WHTCF) (“WELL” or the “Company“) a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI Inc. (TSX:AIDX) (OTCQX: HWAIF) (“HEALWELL“), a healthcare technology company focused on AI and data science for preventative care, are jointly pleased to announce the launch of WELL’s AI-powered co-pilot for cardiologists exclusively powered by HEALWELL AI, aimed at identifying patients at high risk of cardiovascular disease (“CVD“). This significant expansion of WELL’s AI capabilities builds on the success of its second-generation AI-powered physician co-pilot, WELL AI Decision Support (“WAIDS“), developed exclusively in partnership with HEALWELL. This enhancement adds to its existing rare and chronic disease detection abilities and is an extension to the WAIDS offering.
Related news for (HWAIF)
- HEALWELL AI Leverages Orion Health to Power Entry into US Market
- WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program
- HEALWELL AI to Announce Fiscal First Quarter 2025 Financial Results on May 13, 2025
- WELL Health to Exercise Call Right and Acquire Majority Controlling Interest in HEALWELL AI concurrent with HEALWELL’s Proposed Acquisition of Orion Health
- HEALWELL AI to Announce Fourth Quarter and Year End 2024 Financial Results on March 26, 2025